{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:48:58Z","timestamp":1782737338345,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00108-026-02125-1","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:16:14Z","timestamp":1780910174000},"page":"760-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmunpankreatitis und IgG4-assoziierte Erkrankung","Autoimmune pancreatitis and IgG4-related disease"],"prefix":"10.1007","volume":"67","author":[{"given":"Alexander","family":"Kleger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2125_CR1","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi\u00a0A et\u00a0al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis rheumatology 67:1688\u20131699","journal-title":"Arthritis rheumatology"},{"key":"2125_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart\u00a0PA et\u00a0al (2013) Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 62:1771\u20131776","journal-title":"Gut"},{"key":"2125_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","volume":"17","author":"K Okazaki","year":"2017","unstructured":"Okazaki\u00a0K et\u00a0al (2017) International consensus for the treatment of autoimmune pancreatitis. Pancreatology 17:1\u20136","journal-title":"Pancreatology"},{"key":"2125_CR4","unstructured":"Della-Torre, E. et\u00a0al. in Seminars in Arthritis and Rheumatism. 761-765 (Elsevier)."},{"key":"2125_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.autrev.2014.01.010","volume":"13","author":"K Okazaki","year":"2014","unstructured":"Okazaki\u00a0K, Tomiyama\u00a0T, Mitsuyama\u00a0T, Sumimoto\u00a0K, Uchida\u00a0K (2014) Diagnosis and classification of autoimmune pancreatitis. Autoimmunity reviews 13:451\u2013458","journal-title":"Autoimmunity reviews"},{"key":"2125_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cgh.2009.04.020","volume":"7","author":"ST Chari","year":"2009","unstructured":"Chari\u00a0ST et\u00a0al (2009) A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clinical Gastroenterology and Hepatology 7:1097\u20131103","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2125_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/MPA.0b013e3181b9ee1c","volume":"38","author":"K Okazaki","year":"2009","unstructured":"Okazaki\u00a0K et\u00a0al (2009) Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 38:849\u2013866","journal-title":"Pancreas"},{"key":"2125_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/mr\/roac065","volume":"33","author":"M Kawano","year":"2023","unstructured":"Kawano\u00a0M, Saeki\u00a0T, Ubara\u00a0Y, Matsui\u00a0S (2023) Recent advances in IgG4-related kidney disease. Modern Rheumatology 33:242\u2013251","journal-title":"Modern Rheumatology"},{"key":"2125_CR9","unstructured":"Stone, J. H. in Seminars in diagnostic pathology. 177-190 (Elsevier)."},{"key":"2125_CR10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa\u00a0T, Zen\u00a0Y, Pillai\u00a0S, Stone\u00a0JH (2015) IgG4-related disease. The Lancet 385:1460\u20131471","journal-title":"The Lancet"},{"key":"2125_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/annrheumdis-2018-eular.4749","volume":"77","author":"Z Wallace","year":"2018","unstructured":"Wallace\u00a0Z et\u00a0al (2018) OP0081 Phenotypic subgroups in igg4-related disease\u2013a cluster analysis. Annals of the Rheumatic Diseases 77:91","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2125_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","volume":"105","author":"RC Aalberse","year":"2002","unstructured":"Aalberse\u00a0RC, Schuurman\u00a0J (2002) IgG4 breaking the rules. Immunology 105:9\u201319. https:\/\/doi.org\/10.1046\/j.0019-2805.2001.01341.x","journal-title":"Immunology"},{"key":"2125_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace\u00a0ZS et\u00a0al (2020) The 2019 American College of Rheumatology\/European League against rheumatism classification criteria for IgG4-related disease. Annals of the rheumatic diseases 79:77\u201387","journal-title":"Annals of the rheumatic diseases"},{"key":"2125_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","volume":"40","author":"T Shimosegawa","year":"2011","unstructured":"Shimosegawa\u00a0T et\u00a0al (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352\u2013358","journal-title":"Pancreas"},{"key":"2125_CR15","doi-asserted-by":"crossref","unstructured":"Okazaki, K., Uchida, K. & Chiba, T.\u00a0Recent concept of autoimmune-related pancreatitis. Journal of gastroenterology 36 (2001).","DOI":"10.1007\/s005350170094"},{"key":"2125_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo\u00a0H et\u00a0al (2014) De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. Journal of allergy and clinical immunology 134:679\u2013687","journal-title":"Journal of allergy and clinical immunology"},{"key":"2125_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","volume":"78","author":"ZS Wallace","year":"2019","unstructured":"Wallace\u00a0ZS et\u00a0al (2019) Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Annals of the rheumatic diseases 78:406\u2013412","journal-title":"Annals of the rheumatic diseases"},{"key":"2125_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00535-010-0221-9","volume":"45","author":"T Kamisawa","year":"2010","unstructured":"Kamisawa\u00a0T et\u00a0al (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. Journal of gastroenterology 45:471\u2013477","journal-title":"Journal of gastroenterology"},{"key":"2125_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clinre.2015.06.002","volume":"40","author":"MJ Lian","year":"2016","unstructured":"Lian\u00a0MJ, Liu\u00a0S, Wu\u00a0GY, Liu\u00a0SY (2016) Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: a systematic review with meta-analysis. Clinics and research in hepatology and gastroenterology 40:99\u2013109","journal-title":"Clinics and research in hepatology and gastroenterology"},{"key":"2125_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cgh.2023.12.010","volume":"22","author":"KA Overbeek","year":"2024","unstructured":"Overbeek\u00a0KA et\u00a0al (2024) Type 1 autoimmune pancreatitis in europe: clinical profile and response to treatment. Clinical Gastroenterology and Hepatology 22:994\u20131004","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2125_CR21","unstructured":"Lanzillotta, M. et\u00a0al. Maintenance treatment for type\u00a01 autoimmune pancreatitis: effectiveness and development of the PrescrAIP relapse prediction model. Clinical Gastroenterology and Hepatology (2025)."},{"key":"2125_CR22","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart\u00a0PA et\u00a0al (2013) Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62:1607\u20131615","journal-title":"Gut"},{"key":"2125_CR23","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2025.01.033","volume":"82","author":"J Stone","year":"2025","unstructured":"Stone\u00a0J, Khosroshahi\u00a0A, Zhang\u00a0W (2025) B cell-depleting anti-CD19 monoclonal antibody holds promise for treating IgG4-related cholangitis. Journal of Hepatology 82:940\u2013941","journal-title":"Journal of Hepatology"},{"key":"2125_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ard.2025.05.199","volume":"84","author":"J Stone","year":"2025","unstructured":"Stone\u00a0J et\u00a0al (2025) OP0186 EFFICACY AND SAFETY OF RILZABRUTINIB, AN ORAL BRUTON\u2019S TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IgG4-RELATED DISEASE: RESULTS FROM A 52-WEEK, PHASE 2, OPEN-LABEL, PROOF-OF-CONCEPT STUDY. Annals of the Rheumatic Diseases 84:155","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2125_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2025.11.027","volume":"84","author":"V Keitel","year":"2026","unstructured":"Keitel\u00a0V et\u00a0al (2026) CAR T\u2011cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement. J\u00a0Hepatol 84:829\u2013836. https:\/\/doi.org\/10.1016\/j.jhep.2025.11.027","journal-title":"J Hepatol"},{"key":"2125_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers\u00a0MN, Stone\u00a0JH, Deshpande\u00a0V, Khosroshahi\u00a0A (2012) Development of an IgG4-RD responder index. International journal of Rheumatology 2012:259408","journal-title":"International journal of Rheumatology"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02125-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:29:20Z","timestamp":1782736160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02125-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2125"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02125-1","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"A.\u00a0Kleger\n                      : A.\u00a0Finanzielle Interessen: Amgen, Sanofi, Zenas. \u2013\u00a0Amgen.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Direktor, Institut f\u00fcr Molekulare Onkologie und Stammzellbiologie, Uniklinik Ulm; Sektionsleiter Interdisziplin\u00e4re Pankreatologie, Klinik f\u00fcr Innere Medizin\u00a0I, Uniklinik Ulm.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}